New drug regimens in the treatment of tuberculosis.
作者信息
Wolinsky E
出版信息
Bull N Y Acad Med. 1975 Oct;51(9):1096-1102.
Abstract
摘要
相似文献
1
New drug regimens in the treatment of tuberculosis.
Bull N Y Acad Med. 1975 Oct;51(9):1096-1102.
2
Present and new drug regimens in chemotherapy and chemoprophylaxis of tuberculosis.
Bull Int Union Tuberc Lung Dis. 1990 Jun-Sep;65(2-3):86-91.
3
New initiative speeds tuberculosis drug development: novel drug regimens become possible in years, not decades.
Int J Tuberc Lung Dis. 2010 Jun;14(6):663-4.
4
[Treatment of tuberculosis].
Medicina (Firenze). 1989 Oct-Dec;9(4):355-74.
5
Tuberculosis chemotherapy, a review of current treatment regimens.
Singapore Med J. 1982 Feb;23(1):55-60.
6
Anti-tuberculosis regimens of chemotherapy. Recommendations from the Committee on Treatment of the International Union against Tuberculosis and Lung Disease.
Indian J Chest Dis Allied Sci. 1988 Oct-Dec;30(4):296-304.
7
Treatment regimens in HIV-infected tuberculosis patients. An official statement of the International Union Against Tuberculosis and Lung Disease. Paris, 16 September 1997.
Int J Tuberc Lung Dis. 1998 Feb;2(2):175-8.
8
Guidance for national tuberculosis programmes on the management of tuberculosis in children. Chapter 2: anti-tuberculosis treatment in children.
Int J Tuberc Lung Dis. 2006 Nov;10(11):1205-11.
9
[Tuberculosis therapy 1990].
Schweiz Rundsch Med Prax. 1990 May 22;79(21):670-4.
10
Drug-resistant tuberculosis.
Semin Respir Infect. 1986 Dec;1(4):220-9.
引用本文的文献
1
A 44-year experience with tuberculous enterocolitis.
World J Surg. 1977 Mar;2(1):245-50. doi: 10.1007/BF01665095.
2
Tuberculous peritonitis: 43 years' expereince in diagnosis and treatment.
Ann Surg. 1976 Dec;184(6):717-22. doi: 10.1097/00000658-197612000-00010.
本文引用的文献
1
Immunological responsiveness of tuberculosis patients receiving rifampin.
Antimicrob Agents Chemother. 1974 Apr;5(4):383-7. doi: 10.1128/AAC.5.4.383.
2
Infection of children by strains of tubercle bacilli initially resistant to streptomycin or to isoniazid.
Am Rev Respir Dis. 1959 Sep;80:326-39. doi: 10.1164/arrd.1959.80.3.326.
3
Rifampin: in vitro effect on atypical mycobacteria.
Am Rev Respir Dis. 1971 Aug;104(2):272-4. doi: 10.1164/arrd.1971.104.2.272.
4
Potentially serious side effects of high-dose twice-weekly rifampicin.
Br Med J. 1971 Aug 7;3(5770):343-7. doi: 10.1136/bmj.3.5770.343.
5
Effect of rifampicin on liver function in man.
Gut. 1972 May;13(5):366-71. doi: 10.1136/gut.13.5.366.
6
Hepatotoxicity in rifampin-isoniazid treated patients related to their rate of isoniazid inactivation.
Chest. 1972 Jun;61(6):587-8. doi: 10.1378/chest.61.6_supplement.587.
7
In-vitro and in-vivo studies of resistance to rifampin in meningococci.
J Infect Dis. 1971 Apr;123(4):414-20. doi: 10.1093/infdis/123.4.414.
8
Drug-resistant tuberculosis: a review of the world situation.
Tubercle. 1969 Mar;50:Suppl:2-12.
9
Sensitivity to rifampicin: incidence, mechanism, and prevention.
Br Med J. 1974 May 25;2(5916):415-8. doi: 10.1136/bmj.2.5916.415.
10
Side effects of rifampicin. A clinical study.
Scand J Respir Dis Suppl. 1973;82:1-52.
Zotero 插件